C5, Human (Ravulizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-C5, Human (Ravulizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityC5, Human (Ravulizumab biosimilar)
CloneRavulizumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG2-G4 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human C5 Recombinant Antibody (Ravulizumab). Ravulizumab, sold under the brand name Ultomiris, is a humanized monoclonal antibody complement inhibitor medication designed for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome. It is designed to bind to and prevent the activation of Complement component 5 (C5).
Immunogenn/a
Other NamesAnti-C5 Recombinant Antibody, Research Grade Ravulizumab, Anti-Human C5 Recombinant Antibody(Ravulizumab), ALXN-1210, ravulizumab-cwvz, Antibody Drug Analogues, Monoclonal Antibody, YR1443, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1803171-55-2
Catalog #YR1443
Priceplease inquire
Order / More InfoC5, Human (Ravulizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.